title: Reduction of early rejection in adult liver transplantation with ATG induction therapy.
authors.affiliation: Transplantation Service, University Hospitals of Cleveland, OH 44106, USA.
authors.forename: J
authors.initials: J
authors.lastname: Schulak
authors.forename: E
authors.initials: E
authors.lastname: May
authors.forename: A
authors.initials: A
authors.lastname: Post
authors.forename: C
authors.initials: C
authors.lastname: Fasola
authors.forename: D
authors.initials: D
authors.lastname: Mulligan
authors.forename: R
authors.initials: R
authors.lastname: Sterling
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine